✦ LIBER ✦

A Double-blind, Placebo-Controlled, Repeated Dose, Dose-Response Evaluation of Controlled-Release (CR) Oxycodone in Patients with Osteoarthritis

✍ Scribed by Lacouture, P.; Roth, S.; Burch, F.; Fleischmann, R.; Iwan, T.; Kaiko, R.

Book ID: 110019591
Publisher: Nature Publishing Group
Year: 1996
Tongue: English
Weight: 73 KB
Volume: 59
Category: Article
ISSN: 0009-9236
DOI: 10.1038/sj.clpt.1996.17

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute dose-response, double-blind, place

Acute dose-response, double-blind, placebo-controlled pilot study of lercanidipine in patients with angina pectoris

✍ Domenico Acanfora; Mihai Gheorghiade; Domenico Rotiroti; Luigi Trojano; Giuseppe 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 697 KB

Synthetic food coloring and behavior: A

Synthetic food coloring and behavior: A dose response effect in a double-blind, placebo-controlled, repeated-measures study

✍ Katherine S. Rowe; Kenneth J. Rowe 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 638 KB

Atacicept in patients with rheumatoid ar

Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study

✍ P. P. Tak; R. M. Thurlings; C. Rossier; I. Nestorov; A. Dimic; V. Mircetic; M. R 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

Dihydroergocristine in the treatment of

Dihydroergocristine in the treatment of elderly patients with cognitive deterioration: A double-blind, placebo-controlled, dose-response study

✍ Attilio Franciosi; Guido Zavattini 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 572 KB

Tramadol allows reduction of naproxen do

Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: A randomized, double-blind, placebo-controlled study

✍ Thomas J. Schnitzer; Marc Kamin; William H. Olson 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

Subcutaneous apomorphine in patients wit

Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose

✍ Rajesh Pahwa; William C. Koller; Richard M. Trosch; James H. Sherry 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 471 KB